Acurex Biosciences vs Degron Therapeutics
Acurex Biosciences vs Degron Therapeutics, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acurex Biosciences is on 34/100 and Degron Therapeutics on 62/100.
Where each one leads
Acurex Biosciences
Leads on none of the measures we hold for both companies.
Degron Therapeutics
- our overall score: 62/100 against 34/100
- funding raised: $40.0M against $1.0M
At a glance
| Measure | Acurex Biosciences | Degron Therapeutics |
|---|---|---|
| What it is | Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders. | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. |
| Category | Biotechnology, Pharmaceuticals, Neuroscience, Healthcare | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2019 | 2020 |
| Headquarters | San Carlos, USA | San Diego, USA |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Acurex Biosciences | Degron Therapeutics |
|---|---|---|
| Employees | Not published | 24 |
| Total funding | $1.0M | $40.0M |
| Latest round | Grant | Series A Extension |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 1,380 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acurex Biosciences | Degron Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 62/100 |
| Traction | 30/100 | Not published |
| Team | Not published | 24/100 |
| Community | 15/100 | Not published |
| Search visibility | 18/100 | 57/100 |
| Quality | 45/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (27/100) |
| Domain ratingLink authority, 0-100 | Not published | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Acurex Biosciences | Degron Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
Acurex Biosciences vs Degron Therapeutics: common questions
Which is better, Acurex Biosciences or Degron Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do Acurex Biosciences and Degron Therapeutics compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 34/100), funding raised ($40.0M against $1.0M).
Read the full Acurex Biosciences review and pricing or the Degron Therapeutics review and pricing. You can also browse other Acurex Biosciences alternatives we track.